Health care is in the index's top spot for first time since 1988 and looks to remain strong.
Patent expirations are contributing to M&A fever in the biotech sector.
The profitable biotech's two cancer drugs could make it an attractive target.
A pharmaceutical takeover rumor is in the air.
Can they also help boost the company's dormant stock?
The pharma wins US approval for a new rheumatoid arthritis pill, but Abbott's existing treatment isn't likely to suffer a meaningful hit to sales anytime soon.
Exchanges won't reopen until Hurricane Sandy makes landfall. Look for a Wednesday reopen. Insurance companies could see $5 billion to $10 billion in losses. Important economic and earnings reports are due, including Friday's jobs report.
VIDEO ON MSN MONEY
Copyright © 2013 Microsoft. All rights reserved.
The Fed may start tapering in just a few months. Here are a few of the likely winners and losers.
The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.
MONEY & POLITICS
Breaking up big banks is an untested solution to the too big to fail problem that attempts to isolate and dismantle large, troubled institutions while protecting the rest of the economy.
Even those who don't like to shop are probably hitting the stores this month. Here's what to be on the lookout for and here's what to avoid.
The IRS is struggling to combat identify thieves who file fraudulent tax returns in the names of older residents who don't need to file.